Shareholders of Harris & Harris Group, Inc. may be interested in knowing that NanoGram Devices Corporation (www.nanogramdevices.com) has named its President and CEO, Barry Cheskin. Mr. Cheskin has served in a number of senior executive roles in the medical device industry. Most recently, he served as President and CEO of publicly-traded RITA Medical Systems, Inc. (Nasdaq: RITA), a manufacturer of minimally invasive surgical instruments used to treat benign and cancerous tumors.
Harris & Harris Group invested $750,000 in NanoGram Devices in February of 2003. NanoGram Devices has developed and is commercializing specialized power sources for medical devices and other medical equipment based on its patented, laser-based nanomaterial synthesis technology.
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including microsystems, microelectromechanical systems (MEMS) and nanotechnology. The Company's last 10 initial private equity investments have been in tiny-technology enabled companies.
Harris & Harris Group, Inc. is a Business Development Company with 11,498,845 common shares outstanding.
Detailed information about Harris & Harris Group, Inc. and its holdings can be found on its website at http://www.TinyTechVC.com.
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K and recent Prospectus filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc. undertakes no obligation to update or revise these forward-looking-statements to reflect new events or uncertainties.